The Asher Longevity Advisory Board consists of noted experts in the fields of longevity medicine, as well as entrepreneurs and financial professionals who are skilled at bringing longevity innovations to market.  Our Advisory Board makes recommendations and/or provides advice on matters related to the longevity industry, such as research projects, policy initiatives, and clinical standards, along with the commercialization of longevity solutions.

 

Our Advisory Board is also designed to promote collaboration across disciplines by bringing together experts from different areas within our rapidly evolving industry who may be working on similar issues or researching similar topics. This interdisciplinary approach allows longevity providers to share ideas and strategies that may not have been considered otherwise if they were working independently within their own specialty areas.  In turn, this can lead to more effective products and therapeutics, as well as improved longevity outcomes overall.